Skip to main content
Contact Us
Subscribe
E-Edition
82°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Regeneron Pharmaceuticals Inc
Recent news which mentions Regeneron Pharmaceuticals Inc
< Previous
1
2
Next >
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
July 16, 2025
Tags
Social issues
Healthy Returns
Eli Lilly and Co
From
CNBC.com News
Anne Wojcicki to buy back 23andMe and its data for $305 million
June 13, 2025
Tags
Media
Enterprise
Technology
From
CNBC.com News
Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million
May 19, 2025
Tags
Technology
Enterprise
Regeneron Pharmaceuticals Inc
From
CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
April 09, 2025
Tags
Bristol/Myers Squibb Co
Pharmaceuticals
Amgen Inc
From
CNBC.com News
Cramer's Lightning Round: 'We're going to stay away from' Sirius XM
March 11, 2025
Tags
Regeneron Pharmaceuticals Inc
Business
Sirius XM Holdings Inc
From
CNBC.com News
Jim Cramer says he supports healthcare stocks for their long-term value
January 14, 2025
Tags
Merck & Co Inc
Regeneron Pharmaceuticals Inc
Business
From
CNBC.com News
Cramer's Lightning Round: LandBridge is 'a winner'
December 03, 2024
Tags
Business News
Market Outlook
LandBridge Co LLC
From
CNBC.com News
Cramer's week ahead: Fed rate decision, earnings from Darden and Cracker Barrel
September 13, 2024
Tags
Markets
Darden Restaurants Inc
Investing
From
CNBC.com News
Cramer lists his major themes for the market in 2024
January 17, 2024
Tags
Amazon/com Inc
Business News
Business
From
CNBC.com News
Regeneron CEO says the next big thing for biotech isn't AI, it's gene therapy
January 09, 2024
Tags
Markets
stocks
Investing
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Abbott Laboratories
Investment strategy
Stock Picks
From
CNBC.com News
This biotech name is one of Jim Cramer's favorite stocks and he thinks it can go even higher
August 21, 2023
Tags
Biotech and Pharmaceuticals
Regeneron Pharmaceuticals Inc
CNBC Investing Club
From
CNBC.com News
Regeneron shares fall after FDA rejects high-dose eye disease treatment
June 27, 2023
Tags
Regeneron Pharmaceuticals Inc
Business
Biotechnology
From
CNBC.com News
$6 billion in college scholarships are awarded each year. Here's what you need to know about applying
April 04, 2023
Tags
Politics
Student Loans
Labor economy
From
CNBC.com News
Stocks making the biggest moves midday: Block, Deutsche Bank, GameStop, Activision and more
March 24, 2023
Tags
Regeneron Pharmaceuticals Inc
Business
GameStop Corp
From
CNBC.com News
Sanofi, Regeneron shares pop more than 6% after data shows asthma drug Dupixent may also treat COPD
March 23, 2023
Tags
Business News
Breaking News: Business
Business
From
CNBC.com News
Stocks making the biggest moves midday: Netflix, Block, Snap, KB Home and more
March 23, 2023
Tags
Meta Platforms Inc
Breaking News: Markets
Stock markets
From
CNBC.com News
Stocks making the biggest premarket moves: Colgate-Palmolive, Kohl's, Boot Barn and more
January 30, 2023
Tags
Nordstrom Inc
Economy
Breaking News: Markets
From
CNBC.com News
Cramer’s week ahead: Fed decision on Wednesday could let the bulls ‘party on’
January 27, 2023
Tags
Pfizer Inc
Business News
Amazon/com Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Netflix, Alphabet, Nordstrom, PagerDuty and more
January 20, 2023
Tags
PVH Corp
Business
Regeneron Pharmaceuticals Inc
From
CNBC.com News
Stocks making the biggest moves midday: Bed Bath & Beyond, Coinbase, Virgin Orbit and more
January 10, 2023
Tags
Bed Bath & Beyond Inc
Oak Street Health Inc
Regeneron Pharmaceuticals Inc
From
CNBC.com News
Stocks making the biggest moves midday: Tesla, Nvidia, Lululemon and more
January 09, 2023
Tags
Breaking News: Markets
NVIDIA Corp
Marathon Oil Corp
From
CNBC.com News
Jim Cramer says he likes these 5 Nasdaq stocks for 2023
January 05, 2023
Tags
Markets
T/Mobile US Inc
stocks
From
CNBC.com News
Cramer's lightning round: BioXcel Therapeutics may be home run or nothing
November 17, 2022
Tags
Markets
Investing
stocks
From
CNBC.com News
Stocks making the biggest moves midday: Bath & Body Works, Norwegian Cruise Line, Macy's and more
November 17, 2022
Tags
stocks
Target Corp
Markets
From
CNBC.com News
Stocks making the biggest moves midday: Zscaler, DocuSign, Virgin Galactic, Kroger and more
September 09, 2022
Tickers
RH
Tags
Caterpillar Inc
Tesla Inc
National Beverage Corp
From
CNBC.com News
Stocks making the biggest moves premarket: DocuSign, Tesla, RH and more
September 09, 2022
Tickers
RH
Tags
RH
Tesla Inc
Regeneron Pharmaceuticals Inc
From
CNBC.com News
Stocks making the biggest moves midday: GameStop, Rivian, Regeneron, Snap and more
September 08, 2022
Tags
American Eagle Outfitters Inc
Business
Regeneron Pharmaceuticals Inc
From
CNBC.com News
Passage of Inflation Reduction Act gives Medicare historic new powers over drug prices
August 12, 2022
Tags
Bristol/Myers Squibb Co
Health & Science
US Economy
From
CNBC.com News
These are 10 of the best-performing stocks since Jim Cramer's 'Mad Money' debuted on TV
July 18, 2022
Tags
Business News
Monolithic Power Systems Inc
Regeneron Pharmaceuticals Inc
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.